MAM
RMD icon

Martingale Asset Management’s ResMed RMD Stock Holding History

Martingale Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
7,590
-1,850
-20% -$383K 0.04% 452
2026
Q1 		$2.12M Sell
9,440
-1,217
-11% -$303K 0.05% 336
2025
Q4 		$2.57M Sell
10,657
-3,171
-23% -$811K 0.07% 265
2025
Q3 		$3.79M Sell
13,828
-1,628
-11% -$445K 0.1% 187
2025
Q2 		$3.99M Sell
15,456
-222
-1% -$53K 0.1% 168
2025
Q1 		$3.51M Buy
15,678
+6,851
+78% +$1.6M 0.09% 186
2024
Q4 		$2.02M Buy
+8,827
New +$2.13M 0.05% 313
2023
Q1 		– Sell
-3,298
Closed -$686K – 886
2022
Q4 		$686K Sell
3,298
-1,731
-34% -$380K 0.01% 561
2022
Q3 		$1.1M Sell
5,029
-29,531
-85% -$6.72M 0.02% 412
2022
Q2 		$7.25M Sell
34,560
-119,811
-78% -$25.5M 0.13% 160
2022
Q1 		$37.4M Sell
154,371
-19,481
-11% -$4.71M 0.56% 62
2021
Q4 		$45.3M Sell
173,852
-12,517
-7% -$3.25M 0.58% 63
2021
Q3 		$49.1M Sell
186,369
-66,437
-26% -$18.2M 0.64% 49
2021
Q2 		$62.3M Sell
252,806
-13,897
-5% -$2.92M 0.71% 44
2021
Q1 		$51.7M Buy
266,703
+20,142
+8% +$4.04M 0.59% 62
2020
Q4 		$52.4M Buy
246,561
+192,015
+352% +$38.3M 0.59% 56
2020
Q3 		$9.35M Buy
54,546
+25,828
+90% +$4.77M 0.11% 169
2020
Q2 		$5.51M Buy
28,718
+4,107
+17% +$672K 0.07% 295
2020
Q1 		$3.63M Buy
+24,611
New +$3.92M 0.05% 367
2019
Q2 		– Sell
-3,309
Closed -$345K – 1057
2019
Q1 		$345K Sell
3,309
-52,371
-94% -$5.41M ﹤0.01% 935
2018
Q4 		$6.34M Buy
+55,680
New +$5.97M 0.08% 250
2017
Q1 		– Sell
-4,130
Closed -$257K – 982
2016
Q4 		$257K Sell
4,130
-55,102
-93% -$3.37M ﹤0.01% 908
2016
Q3 		$3.84M Sell
59,232
-60,427
-50% -$4.02M 0.06% 346
2016
Q2 		$7.57M Buy
119,659
+47,600
+66% +$2.81M 0.13% 213
2016
Q1 		$4.17M Buy
72,059
+14,950
+26% +$846K 0.08% 244
2015
Q4 		$3.07M Buy
+57,109
New +$3.22M 0.07% 256

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Martingale Asset Management's RMD Position: Q2 2026 in Review

Martingale Asset Management reduced its ResMed (RMD) stake by 20% in Q2 2026, selling an estimated $383K and leaving 7,590 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #452.

Martingale Asset Management first reported a position in RMD in Q4 2015 and has held it in 26 quarters since. The position peaked at $62.3M in Q2 2021. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Martingale Asset Management held 7,590 shares of ResMed worth $1.48M as of Q2 2026.
  • Martingale Asset Management sold 1,850 ResMed shares in Q2 2026, an estimated $383K.
  • ResMed made up 0.04% of Martingale Asset Management's portfolio in Q2 2026, its #452 holding.
  • Martingale Asset Management first reported a position in ResMed in Q4 2015 and has held it in 26 quarters since.
  • Martingale Asset Management's ResMed position peaked at $62.3M in Q2 2021.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.